8.4 Hz, 2H), 7.40 (d, J = 16.2 Hz, 1H), 7.00 (d, J = 4.8 Hz, 1H),
6.97 (d, J = 4.8 Hz, 1H), 6.72 (d, J = 3.6 Hz, 1H), 6.70 (d, J =
8.4 Hz, 2H), 6.47 (dd, J = 1.8 Hz, 3.3 Hz, 1H), 4.10 (s, br, 2H).
13C NMR (CD2Cl2): δ = 159.8, 149.5, 141.3, 140.9, 138.3,
137.5, 134.6, 134.1, 133.0, 130.8, 130.3, 130.2, 128.6, 126.5,
126.3, 118.3, 116.5, 115.1, 114.6. MS (EI): m/z (%) = 385
(100.0), 384 (30.1), 364 (20.6), 288 (4.1), 192 (4.8).
HRMS (EI): calcd for C23H18BF2N3 385.1562; found:
385.1559.
Synthesis of compound 5. Propargyl bromide (0.174 mL, 80%
solution in toluene, 1.6 mmol) and potassium carbonate
(276.4 mg, 2 mmol) were added to a solution of compound 4
(269.6 mg, 0.7 mmol) in acetone (5 mL). The reaction mixture
was refluxed for two days. The solvent was evaporated under
reduced pressure, and the crude product was purified by column
chromatography (ethyl acetate–hexane, 1 : 5) to give compound
5 as a violet solid. Yield 87%, 281.5 mg. Melting point
Fig. 8 Hg2+-treated HeLa cell images. (Top left) Bright field image;
(Top right) fluorescence image; and (Bottom) merged image.
1
156–157 °C. H NMR (CD3CN): δ = 7.76 (s, 1H), 7.49–7.67
(m, 9H), 7.16 (d, J = 4.8 Hz, 1H), 7.05 (d, J = 8.0 Hz, 1H), 7.01
(d, J = 9.0 Hz, 2H), 6.76 (d, J = 3.9 Hz, 1H), 6.53 (dd, J = 2.1
Hz, 3.9 Hz, 1H), 4.25 (d, J = 2.4 Hz, 4H), 2.56 (t, J = 2.4 Hz,
2H). 13C NMR (CD3CN): δ = 160.4, 149.7, 142.0, 141.8, 139.0,
137.9, 134.9, 134.5, 133.9, 131.4, 131.1, 130.3, 129.3, 127.2,
119.5, 118.3, 117.3, 115.4, 115.3, 79.9, 74.0, 40.8. MS (ESI):
m/z = 462.1 [M + H]+; HRMS (ESI): calcd C29H22BF2N3
[M + H]+ 462.1953; found 462.1944.
(t, J = 3.0 Hz, 1H), 5.75 (d, J = 3.3 Hz, 1H), 5.73 (dd, J =
1.8 Hz, 2.1 Hz, 1H), 5.45 (s, 1H). 13C NMR (CD3OD): δ =
146.9, 146.7, 144.2, 139.0, 133.9, 131.4, 129.6, 129.2, 127.5,
126.7, 125.3, 125.0, 120.2, 118.2, 112.8, 110.3, 108.1, 107.8,
45.5. MS(FAB): m/z
= 369. HRMS (FAB): calcd for
C23H19N3O4: 369.1477; found 369.1481.
Synthesis of MS1. Picolyl azide (160.9 mg, 1.2 mmol),
CuSO4·5H2O, (15.0 mg, 10 mol%), and sodium ascorbate
(30.0 mg, 20 mol%) were added to a solution of compound 5
(277.3 mg, 0.6 mmol) in THF–H2O (7 : 3, v/v; 15 mL) under
nitrogen. The solution was stirred at room temperature for 12 h.
A saturated ammonium chloride solution (20 mL) was added to
the reaction mixture, and the organic phase was extracted with
dichloromethane (100 mL, 3×). The combined organic extracts
were dried with anhydrous MgSO4. The solvent was evaporated
under reduced pressure, and the crude product was purified by
column chromatography (dichloromethane–methanol, 20 : 1) to
give compound MS1 as a dark violet solid. Yield 71%,
311.1 mg. Melting point 94–95 °C. 1H NMR (CD3CN): δ = 8.50
(d, J = 5.0 Hz, 2H), 7.76 (s, 2H), 7.69–7.72 (m, 3H), 7.40–7.59
(m, 9H), 7.26 (dd, J = 5.0 Hz, 7.0 Hz, 2H), 7.14 (d, J = 8.0 Hz,
2H), 7.06 (d, J = 5.0 Hz, 1H), 6.93–6.96 (m, 3H), 6.68 (d, J =
4.0 Hz, 1H), 6.48 (dd, J = 2.5 Hz, 3.8 Hz, 1H), 5.47 (s, 4H),
4.75 (s, 4H). 13C NMR (CD3CN): δ = 161.6, 156.6, 151.4,
151.2, 146.2, 143.2, 141.9, 139.0, 138.8, 138.7, 135.7, 135.1,
134.6, 132.1, 131.7, 131.3, 130.0, 127.2, 126.2, 125.2, 124.8,
123.7, 120.3, 118.9, 117.7, 114.9, 56.6, 47.6. MS (ESI): m/z =
730.2 [M + H]+. HRMS (ESI): calcd for C41H34BF2N11
[M + H]+ 730.3138; found 730.3146.
Synthesis of compound 3. 2,3-Dichloro-5,6-dicyano-1,4-benzo-
quinone (DDQ; 318 mg, 1.4 mmol) dissolved in CH2Cl2
(50 mL) was added to a solution of compound 2 (443 mg,
1.2 mmol) in CH2Cl2 (100 mL) under nitrogen, and the mixture
was stirred for 1 h. It was then treated with Et3N (3.0 mL) and
BF3·OEt2 (4.0 mL) for 3 h. The solvent was evaporated under
reduced pressure, and the crude product was purified by column
chromatography (ethyl acetate–hexane, 1 : 10) to give compound
3 as a pink solid. Yield 78%, 388.6 mg. Melting point
1
265–266 °C. H NMR (CD2Cl2): δ = 8.24 (d, J = 8.7 Hz, 2H),
7.87 (s, 1H), 7.83 (d, J = 16.8 Hz, 1H), 7.76 (d, J = 9 Hz, 2H),
7.52–7.61 (m, 5H), 7.43 (d, J = 16.5 Hz, 1H), 7.04 (d, J =
4.5 Hz, 1H), 7.00 (d, J = 4.8 Hz, 1H), 6.90 (d, J = 3.9 Hz, 1H),
6.58 (d, J = 2.1 Hz, 1H). 13C NMR (CD2Cl2): δ = 155.6, 148.1,
148.0, 145.0, 142.7, 142.6, 137.4, 135.2, 134.2, 132.5, 130.95,
130.90, 130.3, 128.8, 128.4, 124.5, 123.0, 118.5, 117.8. MS
(EI): m/z (%) = 415 (100.0), 414 (30.1), 349 (8.4), 347 (10.4),
291 (5.1), 174 (4.8); HRMS (EI): calcd for C23H16BF2N3O4
415.1304; found: 415.1303.
Synthesis of compound 4. Iron powder (803.5 mg,
14.4 mmol) and water (4 mL) were added to a solution of com-
pound 3 (373.6 mg, 0.9 mmol) in methanol (12 mL). It was then
treated with HCl in methanol (6 mL, 0.5 mol L−1). The reaction
mixture was heated at 80 °C for 6 h. The reaction mixture was
cooled to room temperature, and concentrated at reduced
pressure. The crude product was purified by column chromato-
graphy (ethyl acetate–hexane, 1 : 3) to give a blue solid. Yield
80%, 277.3 mg). Melting point 238–239 °C. 1H NMR
(CD2Cl2): δ = 7.69 (s, 1H), 7.48–7.57 (m, 6H), 7.47 (d, J =
Determination of the binding stoichiometry and the
apparent dissociation constants for the binding of
Hg(II) to MS1
The binding stoichiometry of MS1–Hg2+ complexes was deter-
mined from a Job plot.11 The fluorescence intensity at 650 nm
This journal is © The Royal Society of Chemistry 2012
Org. Biomol. Chem., 2012, 10, 5410–5416 | 5415